Company / Gross Profit
Amgen Gross Profit History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$4.2B
FY2019
5-year range
-
FY2016-FY2019
Trend
-3.8%
vs FY2018
Sector context
#5 of 27
Health Care
What the data says
Amgen's gross profit of $4.2B is higher than 81% of companies in the Health Care sector (FY2019). Gross Profit remained relatively stable over the past 4 years, with values between $4.2B and $4.4B.
Based on SEC 10-K filings.
$4.2B in FY2019 with a 3-year CAGR of +0.1%. Top quartile in the Health Care sector.
Remained stable around $4.2B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 27This company $4.2B Sector average $3.7B
▼
+14.7% above sector average
Key checks
Key Insights
- 3-year CAGR of +0.1%, indicating consistent growth.
- In FY2019, gross profit decreased 3.8% year-over-year.
- Ranks #5 out of 27 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $4.2B | -3.8% |
| FY2018 | $4.4B | +4.7% |
| FY2017 | $4.2B | -0.4% |
| FY2016 | $4.2B | +9.9% |
As of FY2019 · SEC 10-K · Updated Feb 28, 2026